A citation-based method for searching scientific literature

Iakovos Toumazis, Emily B Tsai, S Ayca Erdogan, Summer S Han, Wenshuai Wan, Ann Leung, Sylvia K Plevritis. JNCI Cancer Spectr 2019
Times Cited: 16







List of co-cited articles
110 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R Aberle, Amanda M Adams, Christine D Berg, William C Black, Jonathan D Clapp, Richard M Fagerstrom, Ilana F Gareen, Constantine Gatsonis, Pamela M Marcus, JoRean D Sicks. N Engl J Med 2011
81

Cost-effectiveness of CT screening in the National Lung Screening Trial.
William C Black, Ilana F Gareen, Samir S Soneji, JoRean D Sicks, Emmett B Keeler, Denise R Aberle, Arash Naeim, Timothy R Church, Gerard A Silvestri, Jeremy Gorelick,[...]. N Engl J Med 2014
337
62

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
Harry J de Koning, Carlijn M van der Aalst, Pim A de Jong, Ernst T Scholten, Kristiaan Nackaerts, Marjolein A Heuvelmans, Jan-Willem J Lammers, Carla Weenink, Uraujh Yousaf-Khan, Nanda Horeweg,[...]. N Engl J Med 2020
895
56

Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Steven D Criss, Pianpian Cao, Mehrad Bastani, Kevin Ten Haaf, Yufan Chen, Deirdre F Sheehan, Erik F Blom, Iakovos Toumazis, Jihyoun Jeon, Harry J de Koning,[...]. Ann Intern Med 2019
43
56

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Kevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, Carlijn M van der Aalst, Sumei Gu, S Elizabeth McGregor, Garth Nicholas, Harry J de Koning, Lawrence F Paszat. PLoS Med 2017
83
50

Cost-effectiveness of computed tomography screening for lung cancer in the United States.
Pamela M McMahon, Chung Yin Kong, Colleen Bouzan, Milton C Weinstein, Lauren E Cipriano, Angela C Tramontano, Bruce E Johnson, Jane C Weeks, G Scott Gazelle. J Thorac Oncol 2011
168
50

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
Alex H Krist, Karina W Davidson, Carol M Mangione, Michael J Barry, Michael Cabana, Aaron B Caughey, Esa M Davis, Katrina E Donahue, Chyke A Doubeni, Martha Kubik,[...]. JAMA 2021
280
50

Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
Harry J de Koning, Rafael Meza, Sylvia K Plevritis, Kevin ten Haaf, Vidit N Munshi, Jihyoun Jeon, Saadet Ayca Erdogan, Chung Yin Kong, Summer S Han, Joost van Rosmalen,[...]. Ann Intern Med 2014
325
43

Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.
Yuki Tomonaga, Kevin Ten Haaf, Thomas Frauenfelder, Malcolm Kohler, Roger D Kouyos, Mohaned Shilaih, Matthias Lorez, Harry J de Koning, Matthias Schwenkglenks, Milo A Puhan. Lung Cancer 2018
29
43


Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
John R Goffin, William M Flanagan, Anthony B Miller, Natalie R Fitzgerald, Saima Memon, Michael C Wolfson, William K Evans. Lung Cancer 2016
33
43


Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Tristan Snowsill, Huiqin Yang, Ed Griffin, Linda Long, Jo Varley-Campbell, Helen Coelho, Sophie Robinson, Chris Hyde. Health Technol Assess 2018
46
37

Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Stephen Wade, Marianne Weber, Michael Caruana, Yoon-Jung Kang, Henry Marshall, Renee Manser, Shalini Vinod, Nicole Rankin, Kwun Fong, Karen Canfell. J Thorac Oncol 2018
21
31


Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
Vaibhav Kumar, Joshua T Cohen, David van Klaveren, Djøra I Soeteman, John B Wong, Peter J Neumann, David M Kent. Ann Intern Med 2018
58
31

Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis.
Bruce S Pyenson, Claudia I Henschke, David F Yankelevitz, Rowena Yip, Ellynne Dec. Am Health Drug Benefits 2014
55
31

Cost-effectiveness of Lung Cancer Screening in Canada.
John R Goffin, William M Flanagan, Anthony B Miller, Natalie R Fitzgerald, Saima Memon, Michael C Wolfson, William K Evans. JAMA Oncol 2015
61
31


Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017.
Heber MacMahon, David P Naidich, Jin Mo Goo, Kyung Soo Lee, Ann N C Leung, John R Mayo, Atul C Mehta, Yoshiharu Ohno, Charles A Powell, Mathias Prokop,[...]. Radiology 2017
980
25

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Kevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, Summer S Han, Chung Yin Kong, Sylvia K Plevritis, Eric J Feuer, Harry J de Koning, Ewout W Steyerberg, Rafael Meza. PLoS Med 2017
149
25

The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency.
Sonya Cressman, Stuart J Peacock, Martin C Tammemägi, William K Evans, Natasha B Leighl, John R Goffin, Alain Tremblay, Geoffrey Liu, Daria Manos, Paul MacEachern,[...]. J Thorac Oncol 2017
73
25


The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
John K Field, Stephen W Duffy, David R Baldwin, Kate E Brain, Anand Devaraj, Tim Eisen, Beverley A Green, John A Holemans, Terry Kavanagh, Keith M Kerr,[...]. Health Technol Assess 2016
134
25


Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Rafael Meza, Jihyoun Jeon, Iakovos Toumazis, Kevin Ten Haaf, Pianpian Cao, Mehrad Bastani, Summer S Han, Erik F Blom, Daniel E Jonas, Eric J Feuer,[...]. JAMA 2021
69
25

Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
Parthiv J Mahadevia, Lee A Fleisher, Kevin D Frick, John Eng, Steven N Goodman, Neil R Powe. JAMA 2003
241
25

Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy.
Giulia Veronesi, Niccolò Navone, Pierluigi Novellis, Elisa Dieci, Luca Toschi, Laura Velutti, Michela Solinas, Elena Vanni, Marco Alloisio, Simone Ghislandi. Lung Cancer 2020
7
57

Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Renee Manser, Andrew Dalton, Rob Carter, Graham Byrnes, Mark Elwood, Donald A Campbell. Lung Cancer 2005
79
25

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
18

Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Cristiano Rampinelli, Paolo De Marco, Daniela Origgi, Patrick Maisonneuve, Monica Casiraghi, Giulia Veronesi, Lorenzo Spaggiari, Massimo Bellomi. BMJ 2017
121
18

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Uraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, Marjolein Heuvelmans, Ernst Scholten, Jan-Willem Lammers, Peter van Ooijen, Kristiaan Nackaerts, Carla Weenink, Harry Groen,[...]. Thorax 2017
156
18

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges.
Luis M Seijo, Nir Peled, Daniel Ajona, Mattia Boeri, John K Field, Gabriella Sozzi, Ruben Pio, Javier J Zulueta, Avrum Spira, Pierre P Massion,[...]. J Thorac Oncol 2019
159
18

Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
Bernardo H L Goulart, Mark E Bensink, David G Mummy, Scott D Ramsey. J Natl Compr Canc Netw 2012
92
18

The cost-effectiveness of the Manchester 'lung health checks', a community-based lung cancer low-dose CT screening pilot.
Sebastian Hinde, Tessa Crilly, Haval Balata, Rachel Bartlett, John Crilly, Phil Barber, Anthony Threlfall, Janet Tonge, Richard Booton, Phil A Crosbie. Lung Cancer 2018
17
18

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Hormuzd A Katki, Stephanie A Kovalchik, Christine D Berg, Li C Cheung, Anil K Chaturvedi. JAMA 2016
169
18

Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials.
Kevin Ten Haaf, Joost van Rosmalen, Harry J de Koning. Cancer Epidemiol Biomarkers Prev 2015
59
18

Probability of cancer in pulmonary nodules detected on first screening CT.
Annette McWilliams, Martin C Tammemagi, John R Mayo, Heidi Roberts, Geoffrey Liu, Kam Soghrati, Kazuhiro Yasufuku, Simon Martel, Francis Laberge, Michel Gingras,[...]. N Engl J Med 2013
677
18


Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model.
Summer S Han, S Ayca Erdogan, Iakovos Toumazis, Ann Leung, Sylvia K Plevritis. Cancer Causes Control 2017
27
18

Smoking and Lung Cancer Mortality in the United States From 2015 to 2065: A Comparative Modeling Approach.
Jihyoun Jeon, Theodore R Holford, David T Levy, Eric J Feuer, Pianpian Cao, Jamie Tam, Lauren Clarke, John Clarke, Chung Yin Kong, Rafael Meza. Ann Intern Med 2018
72
18

Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals' Follow-Up Studies using a multistage carcinogenesis model.
Rafael Meza, William D Hazelton, Graham A Colditz, Suresh H Moolgavkar. Cancer Causes Control 2008
76
18


Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
Richard Jaine, Giorgi Kvizhinadze, Nisha Nair, Tony Blakely. Lung Cancer 2018
11
27

Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores.
Janel Hanmer, William F Lawrence, John P Anderson, Robert M Kaplan, Dennis G Fryback. Med Decis Making 2006
294
18

Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial.
Ilana F Gareen, Fenghai Duan, Erin M Greco, Bradley S Snyder, Phillip M Boiselle, Elyse R Park, Dennis Fryback, Constantine Gatsonis. Cancer 2014
94
18

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON).
K A M van den Bergh, M L Essink-Bot, G J J M Borsboom, E Th Scholten, M Prokop, H J de Koning, R J van Klaveren. Br J Cancer 2010
114
18

Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
Szu-Chun Yang, Wu-Wei Lai, Chien-Chung Lin, Wu-Chou Su, Li-Jung Ku, Jing-Shiang Hwang, Jung-Der Wang. Lung Cancer 2017
31
18

Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model.
Chengyao Sun, Xin Zhang, Sirou Guo, Yang Liu, Liangru Zhou, Jufang Shi, Ning Wu, Zhao Zhai, Guoxiang Liu. BMJ Open 2021
6
50

Cost-effectiveness analysis of lung cancer screening with low-dose computed tomography in an Iranian high-risk population.
Mansur Haji Esmaeili, Farshad Seyednejad, Alireza Mahboub-Ahari, Hosein Ameri, Hadi Abdollahzad, Naser Safaei, Farbod Alinezhad, Mahmood Yousefi. J Med Screen 2021
3
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.